ask="29.94"
ask_size="100"
average_daily_volume="491087"
bid="N/A"
bid_size="N/A"
book_value="6.19"
change="-0.54"
change_from_200_day_moving_average="-1.05"
change_from_50_day_moving_average="-2.76"
change_from_52_week_high="-10.02"
change_From_52_week_low="15.31"
change_in_percent="-1.83%"
close="28.90"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.06"
ebitda="-175.77M"
eps_estimate_current_year="-3.83"
eps_estimate_next_quarter="-1.03"
eps_estimate_next_year="-3.92"
ex_dividend_date="N/A"
float_shares="31803000"
high="29.51"
high_52_weeks="38.92"
last_trade_date="1/26/2017"
last_trade_price="28.90"
last_trade_size="22423"
last_trade_time="4:00pm"
low="28.59"
low_52_weeks="13.59"
market_capitalization="1.50B"
moving_average_200_day="29.95"
moving_average_50_day="31.66"
name="Theravance Biopharma
Inc. - Or"
notes="N/A"
one_year_target_price="34.71"
open="29.40"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="-3.50%"
percent_change_from_50_day_moving_average="-8.72%"
percent_change_from_52_week_high="-25.74%"
percent_change_from_52_week_low="+112.66%"
previous_close="29.44"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.75"
price_per_sales="32.64"
revenue="46.85M"
shares_outstanding="51942000"
short_ratio="16.78"
stock_exchange="NGM"
symbol="TBPH"
volume="137413"
weeks_range_52="13.59 - 38.92"
